Please try another search
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
AddLife | 124.30 | 124.60 | 122.70 | +2.70 | +2.22% | 34.11K | 03:33:18 | ||
Arjo | 45.00 | 45.52 | 44.94 | -0.38 | -0.84% | 15.86K | 03:35:47 | ||
Bactiguard Holding AB | 71.80 | 72.00 | 69.00 | +0.40 | +0.56% | 3.59K | 03:25:04 | ||
BICO Group | 44.26 | 44.58 | 43.14 | +0.18 | +0.41% | 29.35K | 03:31:24 | ||
Boule Diagnostics | 11.15 | 11.50 | 11.15 | -0.05 | -0.45% | 187.00 | 03:04:33 | ||
C-Rad | 44.10 | 44.10 | 42.90 | +1.25 | +2.92% | 5.57K | 03:33:48 | ||
CellaVision AB | 248.50 | 254.50 | 247.00 | -6.50 | -2.55% | 1.82K | 03:34:22 | ||
Elekta B | 66.90 | 67.00 | 66.20 | +0.10 | +0.15% | 168.09K | 03:35:51 | ||
Episurf Medical AB | 0.28 | 0.28 | 0.27 | -0.01 | -3.57% | 116.09K | 03:33:23 | ||
Getinge B | 182.9 | 183.1 | 182.0 | +0.4 | +0.19% | 43.51K | 03:35:22 | ||
Immunovia publ AB | 1.63 | 1.71 | 1.61 | -0.08 | -4.68% | 38.72K | 03:32:45 | ||
Ortivus A | 4.200 | 4.200 | 4.200 | -0.080 | -1.87% | 180.00 | 03:00:02 | ||
Ortivus B | 2.670 | 2.670 | 2.660 | +0.010 | +0.38% | 345.00 | 03:23:51 | ||
Q linea | 5.03 | 5.60 | 3.90 | +1.23 | +32.19% | 2.34M | 03:35:54 | ||
RaySearch Labs B | 147.80 | 149.40 | 147.00 | +0.20 | +0.14% | 1.65K | 03:27:42 | ||
Sectra | 252.40 | 252.40 | 249.00 | +2.00 | +0.80% | 4.20K | 03:29:58 | ||
Sedana Medical | 25.15 | 25.65 | 25.15 | -0.45 | -1.76% | 10.77K | 03:34:47 | ||
Senzime | 7.9200 | 7.9200 | 7.3200 | +0.3800 | +5.04% | 134.85K | 03:32:17 | ||
Vitrolife | 176.90 | 176.90 | 175.00 | +1.20 | +0.68% | 1.87K | 03:35:25 | ||
Xvivo Perfusion AB | 455.50 | 456.00 | 453.50 | +2.00 | +0.44% | 2.19K | 03:19:13 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review